# Eloxx Pharmaceuticals, Inc.: Form 8-K, filed Mar 9, 2023

- Company: [Eloxx Pharmaceuticals, Inc.](/companies/elox.md) (CIK 1035354)
- Form: 8-K
- Filed: 2023-03-09
- Accepted by EDGAR: Mar 9, 2023, 21:12 ET
- Period: 2023-03-07
- Accession: 0000950170-23-007032
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1035354/000095017023007032/elox-20230307.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1035354/000095017023007032/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 2.03: New direct financial obligation

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1035354/000095017023007032/elox-20230307.htm

Filed Mar 9, 2023.
Source: SEC EDGAR, the filing index for accession 0000950170-23-007032. Last ingested by Listed: Oct 24, 2026, 15:04 ET. No prices; not investment advice.